Core Team

R&D Team

InnoDrug’s core R&D team is led by scientific experts with world-class academic credentials

Professor Zhu Yizhun

Founder & Chairman of the Board

  • M.D., Heidelberg University
  • Member, European Academy of Sciences and Arts
  • Vice President & Founding Dean, Faculty of Chinese Medicine, MUST
  • Chair Professor of Pharmacology
  • Former Dean & Distinguished Professor, School of Pharmacy, Fudan University
  • Chief Scientist, National Major Drug Innovation Program
  • Editor-in-Chief, National Pharmacology Textbook

Professor Erwin Neher

Chief Scientist

  • Member of Four Academies (Göttingen/European/US/UK)
  • Nobel Laureate in Physiology or Medicine
  • Director, Max Planck Institute (1983-2011)
  • Inventor of patch-clamp technique, pioneering targeted drug development for heart disease and epilepsy
  • “Scientist among Scientists” (British Medical Journal)

Professor Zhu Yichun

Chief Medical Officer

  • M.D., Member of European Academy of Sciences and Arts
  • Over 30 years of experience in translational medicine and clinical research
  • Changjiang Scholar, Ministry of Education; State Council Special Allowance Recipient

Dr. Ding Qian

VP, Small Molecule Drug Development

  • Ph.D., Assistant Professor, Faculty of Chinese Medicine, MUST
  • Principal Investigator, 2 Macao Science and Technology Development Fund projects, 5 industry-academia collaborations
  • Winner, 11th AASP Young Scholar Championship

Professor Ye Li

VP, Macromolecule Drug Development

  • Ph.D. in Medicinal Chemistry, Fudan University; Professor & Doctoral Supervisor, MUST
  • Principal Investigator, over 10 national, FDCT, and Shanghai projects
  • Published over 40 SCI papers, 5 authorized patents

Dr. Suguro Rinkiko

VP, Cardiovascular Drug R&D & Clinical Development

  • Ph.D. in Pharmacology, Fudan University; Postdoctoral Researcher, MUST
  • Over 20 years of drug development experience, completed over 20 regulatory submissions
  • Led team to advance 1 first-in-class drug to Phase II clinical trials

Operations Team

InnoDrug’s management team brings extensive experience in global pharmaceutical IPOs and commercialization

Kevin Yin

Chief Executive Officer

  • MBA, University of Gloucestershire, UK
  • Former General Manager, Jilin People’s Pharmaceutical; CEO & Chairman, NASDAQ-listed company
  • Over 20 years of pharmaceutical industry operations and drug development experience

Li Haoran

Board Secretary

  • Master of Communication, Hong Kong Baptist University
  • Over 15 years of brand management and compliance experience in Hong Kong and US-listed companies
  • Former senior executive at Universal Medical and King Fook Holdings (00091.HK)

Dr. Sherry Huang

Vice President

  • Oversees external partnerships and research affairs at InnoDrug
  • Ph.D., Shanghai Normal University Biology, Heidelberg University Medical School, and USJP
  • Over 20 years in biomedical research and industry; former VP at Medicilon and President at Shanghai YABIO

Julia Zhu

VP & Chief Risk Officer

  • B.A. in International Relations, Fudan University; Dual Master’s in Law, LSE and Peking University
  • Previously at Citigroup, Morgan Stanley, and J.P. Morgan with extensive risk management expertise

Martin You

Vice President

  • Oversees finance and treasury management at InnoDrug
  • B.S. in Applied Mathematics and Financial Engineering, Weber State University; M.S. in Business Analytics, University of Utah; Ph.D. in Business Management, MUST
  • Previously at Goldman Sachs (US), China Merchants Bank (Shanghai), and Banco Nacional Ultramarino (Macau) with extensive financial sector experience